{"id":9804,"date":"2023-01-11T07:28:08","date_gmt":"2023-01-11T12:28:08","guid":{"rendered":"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/?p=9804"},"modified":"2024-10-31T08:55:30","modified_gmt":"2024-10-31T12:55:30","slug":"disrupting-life-science-how-vhh-antibodies-will-shape-future-research","status":"publish","type":"post","link":"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/company-news\/disrupting-life-science-how-vhh-antibodies-will-shape-future-research\/","title":{"rendered":"Disrupting life science: How VHH antibodies will shape future research"},"content":{"rendered":"\n\n\n\t<div class=\"dkpdf-button-container\" style=\" text-align:right \">\n\n\t\t<a class=\"dkpdf-button\" href=\"\/secondary-antibody-resource\/wp-json\/wp\/v2\/posts\/9804?pdf=9804\" target=\"_blank\"><span class=\"dkpdf-button-icon\"><i class=\"fa fa-file-pdf-o\"><\/i><\/span> Download PDF<\/a>\n\n\t<\/div>\n\n\n\n\n\n<style>.entry p, .entry ol{font-size: 1rem;}.entry h3{color:#009fe3;margin-top:0}.entry h4{color:#009453;margin-top:1.5rem}.entry h5{color: #003a5c; font-size: 1.05rem;margin-top:1.5rem;}.entry figure{margin:32px auto;border:1px solid #ccc}.entry figure img{width:100%;display:block;margin:0 auto}.entry figcaption{font-size:.875rem;line-height:1.35rem;padding:10px;color:#222}.entry .blog-tbl{margin:1rem auto;caption-side:bottom}.entry .blog-tbl td,.entry .blog-tbl th{padding:10px 9px;border:1px solid #00172b;text-align:left}.entry .blog-tbl td{border-color:#003a5c}.entry .blog-tbl th{background-color:#00172b;color:#fff;border-left-color:#fff;border-right-color:#fff}.entry .blog-tbl th p{color:#fff}.entry .blog-tbl th:first-of-type{border-left-color:#00172b}.entry .blog-tbl th:last-of-type{border-right-color:#00172b}.entry .blog-tbl p{text-align:left;margin:0}.entry .box-note{border:2px solid #009453;padding:12px;margin:1rem 0}.entry .box-note p{margin:0;padding:0}.entry .styled-list{list-style-type:none}.entry .styled-list li{margin-top:1rem;line-height:1rem;font-size:1rem;}.entry .styled-list li::before{font-family:\"Font Awesome 5 Pro\";display:inline-block;content:\"\\f3c5\";-webkit-transform:rotate(-90deg);transform:rotate(-90deg);margin-left:-20px;margin-right:11px;font-size:.75rem;color:#ed7004;font-weight:600}.entry .styled-list ol li::before{display:none}.entry .styled-list li>ul li::before{font-weight:200}.entry .overview{width:-webkit-fit-content;width:-moz-fit-content;width:fit-content;padding:16px;margin:1rem auto;border:1px solid #eee}.entry .overview hr{margin-top:14px}.entry .overview-text{text-align:center;font-size:1rem;margin:0}.entry .btn-sq{color:#fff;font-size:.9rem;font-weight:600;border:2px solid rgb(237, 112, 4);padding:7px 13px;background:rgb(237, 112, 4);cursor:pointer;text-align:center;line-height:1.5rem;margin:0 auto;}.entry .btn-sq:hover{text-decoration:none;color:rgb(237, 112, 4);background:#fff;}.entry .btn-container{display:flex;width:100%;margin:1.3rem 0;}.entry .btn-container .fa-solid, .entry .btn-container .fa-duotone{margin-right:10px;}@media(max-width: 768px){.entry .btn-sq{font-size:1.05rem;}}<\/style>\n<style>.yt-player{width:100%;height:388px;}@media(max-width:980px){.yt-player{height:296px}}<\/style>\n<p>The unique properties of single-variable domain or heavy-chain only antibodies (nanobodies) have revolutionized how researchers exploit antibodies to resolve essential questions in life science research and diagnostics, and even generate novel therapeutics.<\/p>\n<p><iframe class=\"yt-player\" title=\"YouTube video player\" src=\"https:\/\/www.youtube.com\/embed\/nz1OToErumU\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<div>\n<p>Natalie Castellana, Ph.D. SPEAKER<\/p>\n<p>Brian Chait, D. Phil. SPEAKER<\/p>\n<p>John Aitchison, Ph.D. SPEAKER<\/p>\n<p>Jackie Oberst, Ph.D. MODERATOR<\/p>\n<\/div>\n<p>In this webinar, our diverse panel of thought leaders will discuss the potential impact of VHH antibodies on life science research and touch on how these tools will transform technologies for imaging, diagnostics, and therapeutics.<\/p>\n<p><strong>This webinar will last for approximately 60 minutes.<\/strong><\/p>\n<p><strong>Learn more about\u00a0JIR Anti-Camelid Secondary Antibodies for nanobody development\u00a0<a href=\"https:\/\/www.jacksonimmuno.com\/technical\/products\/groups\/whole-igg\/Anti-Camelid\">here<\/a><\/strong><\/p>\n<\/p>\n<table class=\"table blogLinks\">\n<thead>\n<tr>\n<th>Learn more:<\/th>\n<th>Do more:<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td><a href=\"https:\/\/www.jacksonimmuno.com\/technical\/products\/groups\/whole-igg\/Anti-Camelid\">Anti-Camelid\u00a0Secondary Antibodies<\/a><\/td>\n<td><a href=\"\/home\/exhibitions\">Exhibition schedule<\/a><\/td>\n<\/tr>\n<tr>\n<td><a href=\"\/technical\/products\/antibody-selection\">Choosing your secondary antibod<\/a>y<\/td>\n<td><a href=\"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/company-news\/travel-grant-2019\/\">2019 Travel grant<\/a><\/td>\n<\/tr>\n<tr>\n<td><a href=\"\/secondary-antibody-resource\/immuno-techniques\/colorimetric-western-blotting\/\">Colorimetric Western blotting<\/a><\/td>\n<td><a href=\"\/secondary-antibody-resource\/company-news\/cite-and-win\/\">Cite and win!<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>\n<!-- AddThis Advanced Settings generic via filter on the_content --><!-- AddThis Share Buttons generic via filter on the_content --><!-- AddThis Related Posts generic via filter on the_content -->","protected":false},"excerpt":{"rendered":"<p>Download PDF The unique properties of single-variable domain or heavy-chain only antibodies (nanobodies) have revolutionized how researchers exploit antibodies to resolve essential questions in life science research and diagnostics, and even generate novel therapeutics. Natalie Castellana, Ph.D. SPEAKER Brian Chait, D. Phil. SPEAKER John Aitchison, Ph.D. SPEAKER Jackie Oberst, Ph.D. MODERATOR In this webinar, our [&hellip;]<!-- AddThis Advanced Settings generic via filter on get_the_excerpt --><!-- AddThis Share Buttons generic via filter on get_the_excerpt --><!-- AddThis Related Posts generic via filter on get_the_excerpt --><\/p>\n","protected":false},"author":3,"featured_media":9817,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":""},"categories":[19,20],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-json\/wp\/v2\/posts\/9804"}],"collection":[{"href":"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-json\/wp\/v2\/comments?post=9804"}],"version-history":[{"count":10,"href":"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-json\/wp\/v2\/posts\/9804\/revisions"}],"predecessor-version":[{"id":11480,"href":"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-json\/wp\/v2\/posts\/9804\/revisions\/11480"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-json\/wp\/v2\/media\/9817"}],"wp:attachment":[{"href":"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-json\/wp\/v2\/media?parent=9804"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-json\/wp\/v2\/categories?post=9804"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.jacksonimmuno.com\/secondary-antibody-resource\/wp-json\/wp\/v2\/tags?post=9804"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}